Hims & Hers Health, Inc.
Price Action
Technical Summary
CONSOLIDATINGHims & Hers Health, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 84), indicating clear outperformance against the broad market. Earnings contraction of 300% provides fundamental context to the price action. However, price is extended 32% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $28.17 | +25.90% | ABOVE |
| 50 SMA | $26.92 | +31.76% | ABOVE |
| 100 SMA | $23.62 | +50.15% | ABOVE |
| 150 SMA | $27.37 | +29.59% | ABOVE |
| 200 SMA | $33.30 | +6.51% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HIMS in an uptrend right now?
HIMS has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is HIMS overbought or oversold?
HIMS's RSI (14) is 64. The stock is in neutral territory, neither overbought nor oversold.
Is HIMS outperforming the market?
HIMS has a Relative Strength (RS) Rating of 84 out of 99. Yes, HIMS is a market leader, outperforming 84% of all stocks over the past 12 months.
Where is HIMS in its 52-week range?
HIMS is trading at $35.47, which is 50% of its 52-week high ($70.43) and 38% above its 52-week low ($13.74).
How volatile is HIMS?
HIMS has a Beta of 2.56 and 52-week volatility of 98%. It's more volatile than the S&P 500 - expect bigger swings.